| ||||||||||||||
|
|
|||||||||||||



,
*Department of Anaesthesia, University of Toronto;
Division of Cardiac Surgery, Toronto General Hospital, University Health Network;
Department of Anaesthesia, University Health Network, University of Toronto; and
Department of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada
Address correspondence and reprint requests to Vivek Rao, MD, PhD, FRCSC, Division of Cardiac Surgery, Department of Surgery, University of Toronto, EN 14-222, Toronto General Hospital, University Health Network, 200 Elizabeth St., Toronto, Ontario, M5G 2C4, Canada. Address e-mail to vivek.rao{at}uhn.on.ca
Renal insufficiency after cardiac surgery is associated with increased mortality, morbidity, and length of intensive care unit stay. A convenient surrogate measure would facilitate the evaluation of renal-protective therapies. We evaluated two measures: the 72-h change in serum creatinine (Cr) (
Cr72h) and the percentage 72-h change in calculated (Cockcroft-Gault equation) Cr clearance (%
CrCl72h). We randomly selected 2000 individuals who underwent aortocoronary bypass, valve surgery, or both at the Toronto General Hospital between May 1999 and August 2000. The variables were analyzed with frequency histograms and normal probability plots. Their association with dialysis, mortality, and prolonged intensive care unit stay was determined by using receiver operating characteristic (ROC) curves.
Cr72h was skewed to the right, whereas %
CrCl72h was normally distributed. ROC curve areas showed
Cr72h to be a good predictor of dialysis (0.98), death (0.83), and prolonged hospitalization (0.74). %
CrCl72h had similar ROC curve areas for predicting dialysis (0.97), death (0.82), and prolonged hospitalization (0.74). ROC curve areas did not differ significantly with respect to mortality (P = 0.89), dialysis (P = 0.49), or prolonged hospitalization (P = 0.85). Both variables were correlated with patient-relevant outcomes. Mathematical transformation of
Cr72h to %
CrCl72h results in a normal distribution that is amenable to parametric statistical tests.
Cr72h and %
CrCl72h may be used as surrogate outcomes in future trials.
IMPLICATIONS: A convenient surrogate measure of renal function is needed for evaluating renal-protective therapies in cardiac surgery. We evaluated the performance of serum creatinine concentration and calculated creatinine clearance for predicting dialysis, mortality, and prolonged hospitalization. Both measures were correlated with clinical outcomes. Creatinine clearance had the advantage of a distribution suitable for parametric statistical tests.
This article has been cited by other articles:
![]() |
A. Candela-Toha, E. Elias-Martin, V. Abraira, M. T. Tenorio, D. Parise, A. de Pablo, T. Centella, and F. Liano Predicting Acute Renal Failure after Cardiac Surgery: External Validation of Two New Clinical Scores Clin. J. Am. Soc. Nephrol., September 1, 2008; 3(5): 1260 - 1265. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Lindvall, U. Sartipy, T. Ivert, and J. van der Linden Aprotinin is not associated with postoperative renal impairment after primary coronary surgery. Ann. Thorac. Surg., July 1, 2008; 86(1): 13 - 19. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. N. Wijeysundera, W. S. Beattie, V. Rao, J. T. Granton, and C. T. Chan N-acetylcysteine for preventing acute kidney injury in cardiac surgery patients with pre-existing moderate renal insufficiency: [Recours a la N-acetylcysteine pour prevenir une atteinte renale aigue chez les patients de chirurgie cardiaque souffrant d'une insuffisance renale moderee preexistante] Can J Anesth, November 1, 2007; 54(11): 872 - 881. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. H. Chen, T. M. Sundt, D. J. Cook, D. M. Heublein, and J. C Burnett Jr Low Dose Nesiritide and the Preservation of Renal Function in Patients With Renal Dysfunction Undergoing Cardiopulmonary-Bypass Surgery: A Double-Blind Placebo-Controlled Pilot Study Circulation, September 11, 2007; 116(11_suppl): I-134 - I-138. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Simon, R. Luciani, F. Capuano, A. Miceli, A. Roscitano, E. Tonelli, and R. Sinatra Mild and moderate renal dysfunction: impact on short-term outcome Eur. J. Cardiothorac. Surg., August 1, 2007; 32(2): 286 - 290. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. S. Beattie and K. Karkouti Con: Aprotinin Has a Good Efficacy and Safety Profile Relative to Other Alternatives for Prevention of Bleeding in Cardiac Surgery Anesth. Analg., December 1, 2006; 103(6): 1360 - 1364. [Full Text] [PDF] |
||||
![]() |
A. Kuitunen, A. Vento, R. Suojaranta-Ylinen, and V. Pettila Acute Renal Failure After Cardiac Surgery: Evaluation of the RIFLE Classification Ann. Thorac. Surg., February 1, 2006; 81(2): 542 - 546. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Chukwuemeka, A. Weisel, M. Maganti, A. F. Nette, D. N. Wijeysundera, W. S. Beattie, and M. A. Borger Renal Dysfunction in High-Risk Patients After On-Pump and Off-Pump Coronary Artery Bypass Surgery: A Propensity Score Analysis Ann. Thorac. Surg., December 1, 2005; 80(6): 2148 - 2153. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Karkouti, W.S. Beattie, D.N. Wijeysundera, V. Rao, C. Chan, K.M. Dattilo, G. Djaiani, J. Ivanov, J. Karski, and T.E. David Hemodilution during cardiopulmonary bypass is an independent risk factor for acute renal failure in adult cardiac surgery J. Thorac. Cardiovasc. Surg., February 1, 2005; 129(2): 391 - 400. [Abstract] [Full Text] [PDF] |
||||
|